The Motivation And Performance Of Mergers And Acquisitions Of Listed Companies In The Pharmaceutical Industry

In this environment,as the important theme of the market competition,the listed companies in our country have been under great pressure.In order to win more space for survival,the listed companies in China must constantly strive to strengthen their own strength to grow and grow.And through their own efforts,strong self,there are two main effective methods,the first is the gradual growth,in the continuous accumulation,a little step by step to enhance their size and strength,this way generally takes a long time.Second,it is the expansion of direct external mergers and acquisitions.This method can rapidly increase the scale of enterprises in a very short time and achieve leapfrog growth.The second ways have become an important way for the growth of many listed companies.As a whole,the implementation of mergers and acquisitions,on the one hand,can revitalize the existing idle assets,on the other hand,make the capital of the enterprise more substantial,and then,through the implementation of mergers and acquisitions,it also accelerates the enterprise.The operation efficiency of existing assets in the industry,to a certain extent,the reorganization and distribution of enterprise elements is an important means and method to improve the strength of enterprises.In addition to the medical properties,the pharmaceutical industry itself can'tbe separated from the hi-tech industry,so it has the attribute of high technology industry.Many drugs can't be produced without a large amount of funds and the powerful support of advanced technology.It has very high added value,but the industry is also faced with very big development in the process of development.However,from the present point of view,the pharmaceutical industry has great potential and is one of the important economic components.How to promote the healthy development of this industry is a problem that many pharmaceutical industry operators consider.At present,many managers of pharmaceutical companies are fully aware of the role of merger and acquisition,and gradually try to adopt M & a mode in practice.Guide the development of the industry.However,the merger itself is very complex,not the perfect result of every merger and acquisition,that is,the opportunity is also a challenge.In the period of-2013 in2012,Watson fully grasped the structural adjustment opportunities of the pharmaceutical industry,tried to try the adjustment of institutions and carried out a series of mergers and acquisitions,which is a very typical example.The case of merger and acquisition.This paper takes Watson biological company as an example,which isdivided into six parts.The first part is the introduction.This paper mainly reviews and reviews the domestic and foreign scholars' research on M & a motivation and M & a performance,and expounds the research train of thought and research method in this paper.The second part is an overview of M & A and M & a performance,and summarizes the economic performance indicators of M & A,laying a theoretical foundation for this analysis.The third part mainly introduces the case of Watson biological company.This paper introduces the main body of mergers and acquisitions-5 Target Corp acquired by Watson biological company from 2012 to 2013,and expounds the implementation process of Watson's biological merger and acquisition.The fourth part is the motivation of Watson's biological mergers and acquisitions and the influencing factors of mergers and acquisitions.The fifth part is the analysis of Watson's performance in the past 6 years before and after the merger.The sixth part is the conclusion and Inspiration of Watson's research on biological mergers and acquisitions.Finally,the conclusion is drawn to encourage enterprises to clear their own development goals,clear the ultimate goal of M & A,prepare for the merger and acquisition,and make a move to promote the development of the enterprises.After analysis,we get the following conclusions: the motivation of the M & A's M& A is to integrate the industrial chain and complete the strategic layout of its industry,but it has not been effectively evaluated in the search for the target enterprise,which leads to the high payment price,the single payment method,and the goal after the merger and acquisition to achieve the goal of the integration of the internal resources of the enterprise.After the merger,it was in a continuous loss.